Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Takin' Care of Lady Business® - S3Ep104: How You Can Avoid Menopause Altogether with Dr. Piraye Yurttas Beim, PhD, Founder and CEO of Celmatix

S3Ep104: How You Can Avoid Menopause Altogether with Dr. Piraye Yurttas Beim, PhD, Founder and CEO of Celmatix

02/22/25 • 36 min

Takin' Care of Lady Business®
Why have we accepted subpar healthcare for women for over a century? No new drugs designed specifically for the female body, a medical system that normalizes our suffering, and a venture capital world that throws only 2% of its money at women-led startups. Enter Dr. Piraye Yurttas Beim, CEO of Celmatix. She’s secured over $150MM in funding, proving that women’s health isn’t a niche—it’s human health. And yet, she was told to bring a man into meetings just to be taken seriously. Imagine that. The very people shaping the future of medicine still don’t believe women deserve a seat at the table. But Dr. Beim didn’t just take a seat—she built the damn table. Celmatix is making menopause a choice, turning fertility treatments into a simple pill, and forcing the world to recognize that women’s health deserves real innovation. This isn’t just medicine—it’s power, progress, and the future we should have had all along. In this episode, you’ll learn: How Celmatix empowers women to age on their own terms by rethinking menopause as a choice. Ways fertility treatments are getting a major upgrade with revolutionizing fertility treatments by replacing painful injections with a simple daily pill. Discover how infertility treatments unfairly burden women with risks, side effects, and costs. How Dr. Beim defied sexism in venture capital, raising $150 million despite being told to bring a man to investor meetings for credibility. Why neglecting women’s health is more than just a medical issue, it’s bad business. Learn More About Dr. Piraye Yurttas Beim, PhD & Celmatix Website: https://www.celmatix.com/ LinkedIn & Twitter/X: @pirayebeim Instagram & Twitter/X: @celmatix Instagram: @boss_ovary About Our Guest Dr. Piraye Yurttas Beim, PhD, is the founder and CEO of Celmatix, a biotech transforming women’s health through groundbreaking medications. A pioneer in ovarian health—a term she coined in 2020—she has spent over 20 years advancing precision medicine for women’s bodies. Inspired by oncology’s genomics revolution, she founded Celmatix in 2009 to drive innovation in reproductive health, decoding the molecular drivers of ovarian function. Under her leadership, Celmatix is developing five cutting-edge drug programs, including an AMH agonist to extend ovarian function and an oral fertility drug to replace IVF injections. An Aspen Global Leadership Network member, she has been recognized by Crain’s 40 Under 40, Goldman Sachs' Most Intriguing Entrepreneurs, Fortune, and Rock Health. Celmatix has been named one of the world’s most innovative companies by Fast Company. She serves on multiple boards, is an active angel investor, and lives in NYC with her three children. She has no plans to experience menopause. Ever. About Our Company, The Justice Dept. A female-focused advisory, consulting, and law firm advocating for female founders, talent, execs, and brands. We represent bo$$ ladies to make them 💰💰. Website: https://www.thejusticedept.com/ Be the Bo$$ of Your Career: https://www.thejusticedept.com/online-course YouTube: www.youtube.com/@jenniferjustice6653 If you love what you are getting out of our show, please subscribe. This is an SMC Production Learn more about your ad choices. Visit megaphone.fm/adchoices
plus icon
bookmark
Why have we accepted subpar healthcare for women for over a century? No new drugs designed specifically for the female body, a medical system that normalizes our suffering, and a venture capital world that throws only 2% of its money at women-led startups. Enter Dr. Piraye Yurttas Beim, CEO of Celmatix. She’s secured over $150MM in funding, proving that women’s health isn’t a niche—it’s human health. And yet, she was told to bring a man into meetings just to be taken seriously. Imagine that. The very people shaping the future of medicine still don’t believe women deserve a seat at the table. But Dr. Beim didn’t just take a seat—she built the damn table. Celmatix is making menopause a choice, turning fertility treatments into a simple pill, and forcing the world to recognize that women’s health deserves real innovation. This isn’t just medicine—it’s power, progress, and the future we should have had all along. In this episode, you’ll learn: How Celmatix empowers women to age on their own terms by rethinking menopause as a choice. Ways fertility treatments are getting a major upgrade with revolutionizing fertility treatments by replacing painful injections with a simple daily pill. Discover how infertility treatments unfairly burden women with risks, side effects, and costs. How Dr. Beim defied sexism in venture capital, raising $150 million despite being told to bring a man to investor meetings for credibility. Why neglecting women’s health is more than just a medical issue, it’s bad business. Learn More About Dr. Piraye Yurttas Beim, PhD & Celmatix Website: https://www.celmatix.com/ LinkedIn & Twitter/X: @pirayebeim Instagram & Twitter/X: @celmatix Instagram: @boss_ovary About Our Guest Dr. Piraye Yurttas Beim, PhD, is the founder and CEO of Celmatix, a biotech transforming women’s health through groundbreaking medications. A pioneer in ovarian health—a term she coined in 2020—she has spent over 20 years advancing precision medicine for women’s bodies. Inspired by oncology’s genomics revolution, she founded Celmatix in 2009 to drive innovation in reproductive health, decoding the molecular drivers of ovarian function. Under her leadership, Celmatix is developing five cutting-edge drug programs, including an AMH agonist to extend ovarian function and an oral fertility drug to replace IVF injections. An Aspen Global Leadership Network member, she has been recognized by Crain’s 40 Under 40, Goldman Sachs' Most Intriguing Entrepreneurs, Fortune, and Rock Health. Celmatix has been named one of the world’s most innovative companies by Fast Company. She serves on multiple boards, is an active angel investor, and lives in NYC with her three children. She has no plans to experience menopause. Ever. About Our Company, The Justice Dept. A female-focused advisory, consulting, and law firm advocating for female founders, talent, execs, and brands. We represent bo$$ ladies to make them 💰💰. Website: https://www.thejusticedept.com/ Be the Bo$$ of Your Career: https://www.thejusticedept.com/online-course YouTube: www.youtube.com/@jenniferjustice6653 If you love what you are getting out of our show, please subscribe. This is an SMC Production Learn more about your ad choices. Visit megaphone.fm/adchoices

Previous Episode

undefined - S3Ep103: Now You Can Grab a Morning-After Pill at 7-Eleven Along with Your Slurpee with Samantha Miller, MSc, MBA, Co-founder & CEO of Cadence OTC

S3Ep103: Now You Can Grab a Morning-After Pill at 7-Eleven Along with Your Slurpee with Samantha Miller, MSc, MBA, Co-founder & CEO of Cadence OTC

Why is it easier to buy a pack of cigarettes than a morning-after pill? That’s the reality for 23 million women in rural areas without easy access to emergency contraception. But that's changing thanks to Samantha Miller, the co-founder and CEO of Cadence OTC. They’re putting the power back where it belongs—in women’s hands—by making emergency contraception available at convenience stores nationwide at half the price of Plan B. This isn’t just about reproductive rights; it’s about freedom, equity, and common sense healthcare. The fact that it’s taken years of relentless effort to make something so essential accessible is proof of how broken the system is. But Samantha and her team aren’t waiting for permission—they’re rewriting the rules and making history. In this episode, you’ll learn: How Cadence OTC is rewriting the rules on birth control by tearing down regulatory and political barriers to make contraception affordable and over-the-counter for all. Why sharing the difference between the morning-after pill and the abortion pill is the first step in making emergency contraception more accessible. How you can help expand access to emergency contraception by sharing the truth about the morning-after pill and the abortion pill. Why getting birth control over the counter is about advocacy finally breaking down outdated barriers, not money or politics. How insurance companies have the power to prevent unintended pregnancies and reduce healthcare costs but aren’t stepping up. Learn More About Samantha Miller & Cadence OTC LinkedIn: @samantha-miller & @cadencehealth Website: https://cadenceotc.com/ Instagram & TikTok: @cadence_otc Facebook: @CadenceOTC About Our Guest Samantha has over 25 years of experience in the pharmaceutical & consumer healthcare industry. She started her career as a scientist, and then found her passion for the business side as well and became an entrepreneurial leader, helping to build several new companies. Samantha is currently co-founder and CEO of an OTC reproductive health company, Cadence OTC, where they are leading the first-in-class Rx to OTC switch to move the birth control pill over-the-counter and bringing emergency contraceptives to convenience stores in healthcare deserts. Prior to co-founding Cadence, Samantha was chief business officer for InCarda Therapeutics and for Dance Biopharm and led corporate development for other pharma companies, including Theravance, Anesiva, Nektar, and Onyx. She began her pharmaceutical industry training as a marketing manager at Procter & Gamble Pharmaceuticals. Ms. Miller received her MSc in microbiology from the University of Rochester School of Medicine and MBA from the University of Rochester Simon School of Business, where she was class marshall. She also holds a B.S. in biochemistry from the University of California at San Diego. About Our Company, The Justice Dept. A female-focused advisory, consulting, and law firm advocating for female founders, talent, execs, and brands. We represent bo$$ ladies to make them 💰💰. Website: https://www.thejusticedept.com/ Be the Bo$$ of Your Career: https://www.thejusticedept.com/online-course YouTube: www.youtube.com/@jenniferjustice6653 If you love what you are getting out of our show, please subscribe. This is an SMC Production Learn more about your ad choices. Visit megaphone.fm/adchoices

Next Episode

undefined - S3Ep105: The Power of Being Unreasonable: How You Can Take Over the Investing World with Kimmy Scotti, Founder & Managing Partner of Neon

S3Ep105: The Power of Being Unreasonable: How You Can Take Over the Investing World with Kimmy Scotti, Founder & Managing Partner of Neon

What’s really keeping women out of investing? It’s not a lack of instincts or resources—it’s the illusion that they don’t belong. My conversation with the Founder and Managing Partner at Neon, Kimmy Scotti, made that crystal clear. The real power move isn’t just making money—it’s understanding the language, the strategy, and the game itself. And Kimmy? She’s rewriting the rules, making sure women aren’t just participants but power players. Her take on being “unreasonable” hit home, too—because real change doesn’t happen by blending in. It happens when you own your space, trust your instincts, and make the world bend to you. In this episode, you’ll learn: The language of investing, hot to take your power, and never feel like an outsider in a game that was never just for men in suits. Why you should invest in what you already love, pay attention to the brands you swear by, and own a piece of something you use, talk about, and watch grow. How to be “unreasonable” by challenging norms, trusting your instincts, stepping into decision-making spaces, and refusing to wait for permission. Take control of your wealth by learning how to invest, make your own financial decisions, and refuse to let anyone else dictate where your money goes. Ways to shift from giving to growing, because while men invest, women donate, and you deserve wealth that works for you. Learn More About Kimmy Scotti & Neon LinkedIn & Instagram: @kimmyscotti About Our Guest Kimmy Scotti is the Founding & Managing Partner at Neon, an early-stage venture capital firm established in 2023. As an investor and serial entrepreneur, Kimmy’s endeavors are multifaceted. Prior to Neon, Kimmy was building and investing as a founding partner at 8VC, a prominent technology and life sciences investment firm, where she invested in category-defining companies, including Blink Health, Maven, Oula, Hill House Home, and Seed. Kimmy remains an advisor to 8VC. In addition to her current work with Neon, Kimmy currently serves on the Board of Directors for JewBelong, the Board of Directors for Breakout Foundation, and on the Senior Advisory Committee to Cornell Tech at Cornell University. She is an active supporter of various charitable initiatives, including women’s reproductive rights, maternal health, and antisemitism. About Our Company, The Justice Dept. A female-focused advisory, consulting, and law firm advocating for female founders, talent, execs, and brands. We represent bo$$ ladies to make them 💰💰. Website: https://www.thejusticedept.com/ Be the Bo$$ of Your Career: https://www.thejusticedept.com/online-course YouTube: www.youtube.com/@jenniferjustice6653 If you love what you are getting out of our show, please subscribe. This is an SMC Production Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/takin-care-of-lady-business-189460/s3ep104-how-you-can-avoid-menopause-altogether-with-dr-piraye-yurttas-85674926"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to s3ep104: how you can avoid menopause altogether with dr. piraye yurttas beim, phd, founder and ceo of celmatix on goodpods" style="width: 225px" /> </a>

Copy